2024-01-01 2024-12-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 12717519 bus:AbridgedAccounts 2024-01-01 2024-12-31 12717519 bus:FRS102 2024-01-01 2024-12-31 12717519 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12717519 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12717519 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12717519 2024-01-01 2024-12-31 12717519 2024-12-31 12717519 bus:RegisteredOffice 2024-01-01 2024-12-31 12717519 core:WithinOneYear 2024-12-31 12717519 core:AfterOneYear 2024-12-31 12717519 2023-01-01 12717519 bus:Director1 2024-01-01 2024-12-31 12717519 bus:Director1 2024-12-31 12717519 bus:Director1 2023-01-01 2023-12-31 12717519 bus:Director2 2024-01-01 2024-12-31 12717519 bus:Director2 2024-12-31 12717519 bus:Director2 2023-01-01 2023-12-31 12717519 bus:CompanySecretary1 2024-01-01 2024-12-31 12717519 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 12717519 2023-01-01 2023-12-31 12717519 2023-12-31 12717519 core:WithinOneYear 2023-12-31 12717519 core:AfterOneYear 2023-12-31 12717519 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 12717519 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 12717519 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 12717519 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 12717519 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 12717519 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 12717519 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 12717519 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12717519 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 12717519 core:Non-currentFinancialInstruments 2024-12-31 12717519 core:Non-currentFinancialInstruments 2023-12-31 12717519 core:ShareCapital 2024-12-31 12717519 core:ShareCapital 2023-12-31 12717519 core:RetainedEarningsAccumulatedLosses 2024-12-31 12717519 core:RetainedEarningsAccumulatedLosses 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12717519
England and Wales

 

 

 


Abridged Accounts

for the year ended 31 December 2024

for

DR. VALKO LIMITED

DR. VALKO LIMITED
Statement of Financial Position
As at 31 December 2024
 
 		 Notes
 		 2024
£		   2023
£
Fixed assets
Intangible fixed assets 50,000    50,000 
Tangible fixed assets 0    30,000 
Financial assets 599,814    599,814 
649,814    679,814 
Current assets
Financial assets 207,296    207,296 
Cash at bank and in hand 40    1,500 
207,336    208,796 
Creditors: amount falling due within one year (940,478)   (985,135)
Net current assets/(liabilities) (733,142)   (776,339)
 
Total assets less current liabilities (83,328)   (96,525)
Net assets/(liabilities) (83,328)   (96,525)
 

Capital and reserves
Called up share capital 330,625    330,625 
Profit and loss account (413,953)   (427,150)
Shareholders fund (83,328)   (96,525)
 
For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime of Part 15 of the Companies Act 2006.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
Signed on behalf of the board of directors:


----------------------------------
Rolf Hess
Director

Date approved: 23 December 2025
1
DR. VALKO LIMITED
Notes to the Accounts
For the year ended 31 December 2024
Statutory Information
DR. VALKO LIMITED is a private limited company, limited by shares, domiciled in England and Wales, registration number 12717519, registration address 42-44 Bishopsgate, London, EC2N 4AH, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The accounts have been prepared under the historical cost convention and in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
2.

Average number of employees

Average number of employees during the year was 0 (2023: 0).
2